We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+10.69%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.63B
AUM Growth
+$354M
Cap. Flow
+$42.2M
Cap. Flow %
0.91%
Top 10 Hldgs %
6.93%
Holding
1,360
New
97
Increased
499
Reduced
329
Closed
106

Top Buys

Rank Stock Value
1
PHIN icon
Phinia Inc
PHIN
+$19.2M
2
TGNA
TEGNA Inc
TGNA
+$16.8M
3
KSS icon
Kohl's
KSS
+$15M
4
CENTA icon
Central Garden & Pet Co Class A
CENTA
+$14.5M
5
ADNT icon
Adient
ADNT
+$12.1M

Sector Composition

Rank Sector Weight
1 Financials 27.28%
2 Consumer Discretionary 14%
3 Industrials 12.72%
4 Technology 9.9%
5 Healthcare 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEE icon
1151
Lee Enterprises
LEE
$182M
$111K ﹤0.01%
12,770
SYRS
1152
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$111K ﹤0.01%
51,500
GEG icon
1153
Great Elm Group
GEG
$69.3M
$110K ﹤0.01%
57,503
-54,866
-49% -$99.9K
ALLK
1154
DELISTED
Allakos
ALLK
$109K ﹤0.01%
167,400
PDYN icon
1155
Palladyne AI
PDYN
$296M
$108K ﹤0.01%
60,400
TCS
1156
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$107K ﹤0.01%
11,582
-4,035
-26% -$46.8K
RLYB icon
1157
Rallybio
RLYB
$85.8M
$107K ﹤0.01%
11,450
-575
-5% -$5.54K
KORE
1158
DELISTED
KORE Group Holdings
KORE
$107K ﹤0.01%
47,156
-2,584
-5% -$6.07K
AWRE icon
1159
Aware
AWRE
$27.7M
$105K ﹤0.01%
56,100
-24,579
-30% -$51.6K
BLUE
1160
DELISTED
bluebird bio
BLUE
$104K ﹤0.01%
10,000
-2,750
-22% -$45.7K
OPAD icon
1161
Offerpad Solutions
OPAD
$23.1M
$103K ﹤0.01%
+2,540
New +$102K
RFL icon
1162
Rafael Holdings
RFL
$107M
$100K ﹤0.01%
52,379
ZVIA icon
1163
Zevia
ZVIA
$111M
$97.2K ﹤0.01%
90,000
NXTC icon
1164
NextCure
NXTC
$26.7M
$96.7K ﹤0.01%
5,883
VOR icon
1165
Vor Biopharma
VOR
$1.28B
$95.1K ﹤0.01%
6,795
-1,500
-18% -$27.3K
UHG
1166
DELISTED
United Homes Group
UHG
$92.1K ﹤0.01%
15,000
AWX icon
1167
Avalon Holdings
AWX
$10.1M
$90.5K ﹤0.01%
35,500
TARA icon
1168
Protara Therapeutics
TARA
$232M
$90K ﹤0.01%
49,200
+25,000
+103% +$51.4K
MRNS
1169
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$88K ﹤0.01%
+50,000
New +$69.8K
VNCE icon
1170
Vince Holding Corp
VNCE
$86.8M
$87.5K ﹤0.01%
47,322
-9,574
-17% -$15.9K
SGMO
1171
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$86.6K ﹤0.01%
+100,000
New +$73.3K
LOAN
1172
Manhattan Bridge Capital
LOAN
$47.1M
$84.8K ﹤0.01%
15,216
FEAM icon
1173
5E Advanced Materials
FEAM
$62.3M
$84.2K ﹤0.01%
6,783
+5,435
+403% +$103K
DNMR
1174
DELISTED
Danimer Scientific, Inc.
DNMR
$84K ﹤0.01%
4,625
ELDN icon
1175
Eledon Pharmaceuticals
ELDN
$285M
$83.2K ﹤0.01%
33,400

Similar funds

Bridgeway Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Bridgeway Capital Management held 1,360 positions worth $4.63B, up 8.3% from $4.27B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.

Bridgeway Capital Management's Q3 2024 filing shows 97 new, 499 increased, 329 reduced and 106 closed positions. Its largest new stake was Phinia Inc: 427,196 shares worth $19.7M. The largest sale was Abercrombie & Fitch, an estimated $11M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q3 2024 buy was Phinia Inc: 427,196 shares worth $19.7M.
  • Bridgeway Capital Management added most to Central Garden & Pet Co Class A in Q3 2024, an estimated $14.5M increase.
  • Bridgeway Capital Management's biggest Q3 2024 reduction was Abercrombie & Fitch, cutting an estimated $11M.
  • Bridgeway Capital Management fully exited CleanSpark in Q3 2024, selling an estimated $7.03M.
  • Bridgeway Capital Management's ten largest holdings make up 6.9% of its $4.63B portfolio in Q3 2024.
  • Bridgeway Capital Management opened 97 new positions and closed 106 in Q3 2024.
  • Bridgeway Capital Management's portfolio value rose 8.3% quarter-over-quarter to $4.63B.

Based on Bridgeway Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.